The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

Share Price Information for Aquis Exchange (AQX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 463.00
Bid: 460.00
Ask: 466.00
Change: -2.00 (-0.43%)
Spread: 6.00 (1.304%)
Open: 465.00
High: 465.00
Low: 463.00
Prev. Close: 465.00
AQX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Jun 2018 08:30

RNS Number : 3412R
Aquis Exchange PLC
14 June 2018
 

Aquis Exchange PLC ("Aquis")

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Following the announcement of the admission of Aquis' ordinary shares of 10p each ("Ordinary Shares") to trading on the AIM market of the London Stock Exchange ("Admission") and Aquis' first day of dealings, Aquis confirms the following interests of its persons discharging managerial responsibilities ("PDMR") in the securities of Aquis arising by virtue of Admission.

As disclosed in its Admission Document, details of all known interests currently held by PDMRs in the issued share capital of Aquis as at Admission are as follows:

Name

Position

Number of Ordinary Shares

Number of Ordinary Shares over which options are granted following Admission

Alasdair Haynes

Chief Executive Officer

1,551,551

120,817

Jonathan Clelland

Chief Financial Officer, Chief Operating Officer and Company Secretary

576,000

120,817

Mark Spanbroek

Non-executive director

319,128

-

 

A. Exercise of Options

Prior to Admission, Jonathan Clelland chose to exercise options pursuant to an existing Enterprise Management Incentive Scheme (where the grantor was Alasdair Haynes) (the "Lapsing Incentive Scheme"). If these options were not exercised, they would have lapsed 40 days after Admission.

The exercise of the following options pursuant to the Lapsing Incentive Scheme took place on the date of Admission:

Name

Number of Ordinary Shares

subject to the option

Exercise Price per Ordinary Share

Jonathan Clelland

57,600

 

£0.0846354167 GBP

288,000

 

£0.1354166667 GBP

145,920

 

£0.2890625000 GBP

 

B. Grant of options

Ahead of Admission, the Board approved the grant of options under the new Aquis Exchange Enterprise Management Incentive Share Option Plan. The grant was approved conditional on Admission. The grant has been made on the date of Admission to the following PDMRs:

 

 

Name

Number of Ordinary Shares

subject to the option

Exercise Price per Ordinary Share

Jonathan Clelland

120,817

£2.69 GBP

Alasdair Haynes

120,817

£2.69 GBP

These options will vest in tranches of one third on each of the 14 June 2019, 14 June 2020 and 14 June 2021, subject to the rules of the plan, and may be exercised prior to 14 June 2028.

C. Sale of Shares 

As disclosed in the Admission Document, on Admission, the following disposals of Ordinary Shares were made by the following PDMRs at the IPO placing price of £2.69:

Name

Number of Ordinary Shares

sold

Jonathan Clelland

99,840

Alasdair Haynes

258,240

 

The attached notifications, made in accordance with requirements of the EU Market Abuse Regulation, give further details of the above transactions.

 

ENQUIRIES

Aquis Exchange PLC

Alasdair Haynes, CEO

Jonathan Clelland, CFO and COO

 

Tel: +44 (0) 20 3597 6321

Liberum Capital Limited (Nominated Adviser and Broker)

Clayton Bush

Chris Clarke

Jill Li

Kane Collings

 

Tel: +44 (0) 20 3100 2000

Finsbury (Financial Public Relations)

Alastair Hetherington

Michael Turner

Alexander Gorokhov

Tel: +44 (0) 20 7251 3801

Website:

http://www.aquis.eu

A. Transaction notification - Exercise of Options

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jonathan Clelland

2.

Reason for the notification

a)

Position / status

Director (Chief Financial Officer, Chief Operations Officer, Company Secretary) - PDMR

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Aquis Exchange PLC

b)

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Exercise of Enterprise Management Incentive share options over Ordinary Shares

GB00BD5JNK30

b)

Nature of the transaction

Exercise of Enterprise Management Incentive ("EMI") options under the Aquis Exchange Limited Enterprise Management Incentive Scheme (adopted pre-Admission)

c)

Price(s) and volume(s)

 

 

 

Price(s) per share (to 10 decimal places)

Volume(s)

£0.0846354167 GBP

£0.1354166667 GBP

£0.2890625000 GBP

57,600

288,000

145,920

d)

Aggregated information

- Aggregated volume

- Price

 

- 491,520

- £86,055 GBP

e)

Date of the transaction

2018-06-14 BST

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

B. Transaction notifications - Grant of options

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jonathan Clelland

2.

Reason for the notification

a)

Position / status

Director (Chief Financial Officer, Chief Operations Officer, Company Secretary) - PDMR

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Enterprise Management Incentive share options over Ordinary Shares

GB00BD5JNK30

b)

Nature of the transaction

Grant of Enterprise Management Incentive ("EMI") options under the Aquis Exchange Limited Enterprise Management Incentive Share Option Plan

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£2.69 GBP

120,817

d)

Aggregated information

- Aggregated volume

- Price

 

- N/A

- £2.69 GBP

e)

Date of the transaction

2018-06-14 BST

f)

Place of the transaction

Outside a trading venue

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Alasdair Haynes

2.

Reason for the notification

b)

Position / status

Director (Chief Executive Officer) - PDMR

c)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Enterprise Management Incentive share options over Ordinary Shares

GB00BD5JNK30

b)

Nature of the transaction

Grant of Enterprise Management Incentive ("EMI") options under the Aquis Exchange Limited Enterprise Management Incentive Share Option Plan

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£2.69 GBP

120,817

d)

Aggregated information

- Aggregated volume

- Price

 

- N/A

- £2.69 GBP

e)

Date of the transaction

2018-06-14 BST

f)

Place of the transaction

Outside a trading venue

 

C. Transaction notification - Sale of ordinary shares

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Alasdair Haynes

2.

Reason for the notification

b)

Position / status

Director (Chief Executive Officer) - PDMR

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares

 

 

GB00BD5JNK30

 

b)

Nature of the transaction

Disposal of Ordinary Shares

c)

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

 

£2.69 GBP

 

258,240

d)

Aggregated information

- Aggregated volume

- Price

 

 

258,240

 

£2.69GBP

e)

Date of the transaction

2018-06-14 BST

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jonathan Clelland

2.

Reason for the notification

b)

Position / status

Director (Chief Financial Officer) - PDMR

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares

 

 

GB00BD5JNK30

b)

Nature of the transaction

 

Disposal of Ordinary Shares

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£2.69GBP

 

99,840

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

99,840

£2.69GBP

e)

Date of the transaction

2018-06-14 BST

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLFFSLRDIVLIT
Date   Source Headline
24th Apr 20207:00 amRNSPublication of ARA and Notice of AGM
20th Apr 20207:00 amRNSIssue of Options and Director/PDMR Notification
16th Apr 20207:00 amRNSFinal results
15th Apr 20207:00 amRNSExercise of Share Options & Total Voting Rights
24th Mar 20207:00 amRNSUpdate to Results Announcement Date
4th Mar 20203:49 pmRNSFCA Approval of NEX Exchange Acquisition
19th Dec 20197:00 amRNSTiming of NEX Exchange Acquisition,Trading Update
22nd Nov 20192:40 pmRNSDirector/PDMR Notification
17th Sep 20197:00 amRNSInterim results for six months ended 30 June 2019
28th Aug 20197:00 amRNSNotice of Results
5th Jul 20197:00 amRNSAcquisition of NEX Exchange
27th Jun 20195:57 pmRNSMarket Update
5th Jun 20197:00 amRNSAquis Exchange achieves record market share
30th Apr 20191:16 pmRNSResult of AGM
29th Mar 20197:00 amRNSPublication of Annual Report and Notice of AGM
20th Mar 20191:30 pmRNSConfirmation of Board Appointment
20th Mar 20197:00 amRNSFinal Results for the year ended 31 December 2018
5th Mar 201911:00 amRNSAquis supplies AkinovA with trading technology
26th Feb 20194:38 pmRNSTR-1: Notification of major holdings
19th Feb 20197:00 amRNSTR-1: Notification of major holdings
24th Jan 20197:00 amRNSFrench Regulatory Approval
8th Jan 20197:00 amRNSTrading Update and Board Appointment
7th Jan 20192:14 pmRNSTR-1: Notification of major holdings
4th Dec 201811:13 amRNSAQUIS EXCHANGE RELEASE NOVEMBER TRADING STATISTICS
26th Nov 201811:10 amRNSStandard form for notification of major holdings
21st Nov 201810:17 amRNSDirector/PDMR Notification
16th Oct 20189:54 amRNSTR-1: Notification of major holdings
25th Sep 20187:00 amRNSInterim Results for six months ended 30 June 2018
6th Sep 20187:00 amRNSTechnology Licensing Agreement
4th Sep 20185:19 pmRNSResult of General Meeting
13th Aug 20185:15 pmRNSNotice of General Meeting
4th Jul 20183:59 pmRNSTR-1: Notification of major holdings
14th Jun 20188:30 amRNSDirector/PDMR Shareholding
14th Jun 20187:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.